Interactions between central opioidergic and cholecystokininergic systems in rats : Possible significance for the development of opioid tolerance;Interactions entre les systèmes opioïdergiques et cholécystokininergiques centraux chez le rat: Implications dans le développement de la tolérance aux opioïdes

Bulletin de l'Academie Nationale de Medecine

Volumn 182, Issue 2, 1998, Pages 311-324

  Benoliel, Jean Jacques ^a,b   Becker, Christel ^a   Mauborgne, Annie ^a,b   Bourgoin, Sylvie ^a   Hamon, Michel ^a   Cesselin, François ^a   Raymond Ardaillou, M ^a,b  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Analgesia; Cholecystokinin; Drug Effects; Morphine; Opioids Peptides; Receptors; Therapeutic use

Indexed keywords

CHOLECYSTOKININ RECEPTOR; MORPHINE; NARCOTIC ANALGESIC AGENT; OPIATE PEPTIDE;

ANIMAL; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; DRUG TOLERANCE; METABOLISM; RAT; REVIEW;

ANALGESICS, OPIOID; ANIMALS; CENTRAL NERVOUS SYSTEM; DRUG TOLERANCE; MORPHINE; OPIOID PEPTIDES; RATS; RECEPTORS, CHOLECYSTOKININ;

EID: 0031610376     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. VANDERHAEGHEN J.J., SIGNEAU J.C., GEPTS W. - New peptide in the vertebrate CNS reacting with gastrin antibodies. Nature, 1975, 257, 604-605.
2. WOODRUFF G.N., HILL D.R., BODEN P., PINNOCK R., SINGH L., HUGHES J. - Functional role of brain CCK receptors. Neuropeptides, 1991, 19 (Suppl.), 45-56.
3. SMITH G.P., GIBBS J. - Satiating effect of cholecystokinin. Ann. N. Y. Acad. Sci., 1994, 713, 236-241.
4. LYDIARD R.B. - Neuropeptides and anxiety : focus on cholecystokinin. Clin. Chem., 1994, 40, 315-318.
5. BASER N.S., DOURISH C.T., HILL D.R. The role of CCK, caerulein, and CCK antagonists in nociception. Pain, 1989, 39, 307-328.
6. CESSELIN F. - Opioid and anti-opioid peptides. Fundam. Clin. Pharmacol., 1995, 9, 409-433.
7. ROTHMAN R.B. - A review of the role of anti-opioid peptides in morphine tolerance and dependence. Synapse, 1992, 12, 129-138.
8. DOURISH C.T., O'NEILL M.F., COUGHLAN J., KITCHENER S.J., HAWLEY D., IVERSEN S.D. The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat. Eur. J. Pharmacol., 1990, 176, 35-44.
9. Xu X.J., HÖKFELT T., HUGHES J., WIESENFELD-HALLIN Z. - The CCK-B antagonist C1988 enhances the reflex-depressive effect of morphine in axotomized rats. Neuroreport, 1994, 5, 718-720.
10. Xu X.J., PUKE M.J.C., VERGE V.M.K., WIESENFELD-HALLIN Z. - Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat. Neurosci. Lett., 1993, 152, 129-132.
11. PANERAI A.E., ROVATI L.C., COCCO E., SACERDOTE P., MANTEGAZZA P. - Dissociation of tolerance and dependence to morphine : a possible role for cholecystokinin. Brain Res., 1987, 410, 52-60.
12. Xu X.J., WIESENFELD-HALLIN Z., HUGHES D.C., HORWELL D.C., HÖKFELT T. - CI 988, a selective antagonist of cholecystokinin B, receptors prevents morphine tolerance in the rat. Br. J. Pharmacol., 1992, 105, 591-596.
13. MALDONADO R., VALVERDE O., DERRIEN M., TEJEDORREAL P., ROQUES B.P. - Effects induced by BC 264, a selective agonist of CCK-B receptors, on morphine-dependent rats. Pharmacol. Biochem. Behav., 1994, 48, 363-369.
14. DERRIEN M., NOBLE F., MALDONADO R., ROQUES B.P. - Cholecystokinin-A but not cholecystokinin-B receptor stimulation induces endogenous opioid-dependent antinociceptive effects in the hot plate test in mice. Neurosci. Lett., 1993, 160, 193-196.
15. NOBLE F., SMADJA C., ROQUES B.P. - Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists. J. Pharmacol. Exp. Ther., 1994, 271, 1127-1134.
16. OSSIPOV M.H., KOVELOWSKI C.J., VANDERAH T., PORRECA F. - Naltrindole, an opioid δ antagonist, blocks the enhancement of morphine-antinociception induced by a CCK-B antagonist in the rat. Neurosci. Lett., 1994, 181, 9-12.
17. BOURGOIN S., BENOLIEL J.J., MAUBORGNE A., HAMON M., CESSELIN F. - Cholecystokinin exerts a tonic excitatory influence on the spinal release of met-enkephalin in the rats. Analgesia, 1994, 1, 323-326.
18. POHL M., COLLIN E., BENOLIEL J.J., BOURGOIN S., CESSELIN F., HAMON M. - Cholecystokinin (CCK)-like material and CCK mRNA levels in the rat brain and spinal cord after acute or repeated morphine treatment. Neuropeptides, 1992, 21, 193-200.
19. DING X.Z., BAYER B.M. - Increases of CCK messenger RNA and peptide content in different brain areas following acute and chronic administration of morphine. Brain Res., 1993, 625, 139-144.
20. ZHOU Y., SUN Y.H., ZHANG Z.W., HAN J.S. - Accelerated expression of cholecystokinin in the brain of rats rendered tolerant to morphine. Neuroreport, 1992, 3, 1121-1123.
21. DHAWAN B.N., CESSELIN F., RAGHUBIR R., REISINE T., BRADLEY P.B., PORTOGHESE P.S., HAMON M. - International union of pharmacology. XII. Classification of opioid receptors. Pharmacol. Rev., 1996, 48, 567-592.
22. BENOLIEL J.J., BOURGOIN S., MAUBORGNE A., LEGRAND J.C., HAMON M., CESSELIN F. Differential inhibitory/stimulatory modulation of spinzal CCK release by μ and δ opioid agonists, and selective blockade of μ-dependent inhibition by x receptor stimulation. Neurosci. Lett., 1991, 124, 204-207.
23. BENOLIEL J.J., COLLIN E., MAUBORGNE A., BOURGOIN S., LEGRAND J.C., HAMON M., CESSELIN F. - Mu and delta opioid receptors mediate opposite modulations by morphine of the spinal release of cholecystokinin-like material. Brain Res., 1994, 653, 81-91.
24. BENOLIEL J.J., MAUBORGNE A., BOURGOIN S., LEGRAND J.C., HAMON M., CESSELIN F. - Opioid control of the in vitro release of cholecystokinin-like material from the rat substantia nigra. J. Neurochem., 1992, 58, 916-922.
25. RODRIGUEZ R.E., SACRISTAN M.P. - In vivo release of CCK-8 from the dorsal horn of the rat : inhibition by DAGOL. FEBS Lett., 1989, 250, 215-217.
26. 3H]pBC264 : evidence for a physiological regulation of CCKergic systems by endogenous enkephalins. J. Neurochem., 1992, 59, 1805-1811.
27. Di PIERO V., FERRACUTI S., SABATINI U., PANTANO P., CRUCCU G., LENZI G.L. - A cerebral blood flow study on tonic pain activation in man. Pain, 1994, 56, 167-173.
28. HARRO J., KIIVET R.A., LANG A., VASAR E. - Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK.-8 and benzodiazepine receptor characteristics. Behav. Brain Res., 1990, 39, 63-71.
29. NEVO I., BECKER C., HAMON M., BENOLIEL J.J. - Stress - and yohimbine-induced release of cholecystokinin in the frontal cortex of freely moving rat - prevention by diazepam but not ondansetron. J. Newrochem., 1996, 66, 2041-2049.
30. STINUS L., LE MOAL M., KOOB G.F. - Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience, 1990, 37, 767-773.
31. ABDELHAMID E.E., SULTANA M., PORTOGHESE P.S., TAKEMORI A.E. - Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J Pharmacol. Exp. Ther., 1991, 258, 299-303.
32. SUZUKI T., TSUJI M., MORI T., MISAWA M., NAGASE H. - Involvement of delta 1 and delta 2 opioid receptor subtypes in the development of physical dependence on morphine in mice. Pharmacol. Biochem. Behav., 1997, 57, 293-299.
33. DERRIEN M., MCCORT-TRANCHEPAIN I., DUCOS B., ROQUES B.P., DURIEUX C. - Heterogeneity of CCK - B receptors involved in animal models of anxiety. Pharmacol. Biochem. Behav., 1994, 49, 133-141.
34. HAMMOND D.L. - Pharmacological mechanisms of pain modulation. An update on δ opioid receptors. In Chapman C.R., Foley K.M. (Eds), Current and emerging issues in cancer pain : research and practice. New York : Raven Press, Ltd., 1993, pp. 175-183.
35. MATTHES H.W.D., MALDONADO R., SIMONIN F., VALVERDE O., SLOWE S., KITCHEN I., BEFORT K., DIERICH A., LE MEUR M., DOLLÉ P., TZAVARA E., HANOUNE J., ROQUES B.P., KIEFFER B.L. - Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid receptor gene. Nature, 1996, 383, 819-823.
36. SORA I.,TAKAHASHI N., FUNADA M., UJIKEH., REVAY R.S., DONOVAN D.M., MINER L.L.,UHL G.R. - Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Natl. Acad. Sci. USA, 1997, 94, 1544-1549.
37. ZADINA J.E., HACKLER L., GE L.J., KASTIN A.J. - A potent and selective endogenous agonist for the μ-opiate receptor. Nature, 1997, 386, 499-502.